semaglutide and mood changes The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy Study links semaglutide and tirzepatide

Root causes vary Doctors, patients and drug companies have learned a lot more in recent years about obesity and what works or doesn't since the new class of obesity treatments known as GLP-1 drugs have come to market

doi: 10.1371/journal.pone.0296190 125

Homocysteine: Friend or Foe

The 2g per vial concentration makes Mesocartin one of the most concentrated single-active L-Carnitine injectable solutions on the South African market, suited to practices that prefer to dose L-Carnitine standalone rather than as part of a compound formulation

In PD, harmful free radicals cause oxidative stress and cellular damage to the dopaminergic neurons

Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics